Display Options:
Total: 968
Antibody
Investigational
Unknown
Unknown
Diabetic Nephropathies
Transforming growth factor beta-1 inhibitor
Antibody
Investigational
Unknown
Unknown
Neoplasms; Carcinoma, Non-Small-Cell Lung
Unknown
Antibody
Investigational
Unknown
Unknown
Colorectal Neoplasms; Lung Neoplasms; Breast Neoplasms; Fallopian Tube Neoplasms; Ovarian Neoplasms; Peritoneal Neoplasms
Lewis Y antigen binding agent
Antibody
Investigational
Unknown
Unknown
Severe Acute Respiratory Syndrome
Unknown
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
Antibody
Investigational
Unknown
Unknown
Hodgkin Disease; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Multiple Myeloma
Tumor necrosis factor receptor superfamily member 5 antagonist
Antibody
Investigational
Unknown
Unknown
Spinal Cord Injuries
Unknown
Antibody
Investigational
Unknown
Unknown
Arthritis, Psoriatic; Arthritis, Rheumatoid
Interleukin 17A inhibitor
Antibody
Investigational
Unknown
Unknown
Unknown
Mucin-1 binding agent
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
Antibody
Investigational
Unknown
Unknown
Unknown
Shiga toxin subunit B inhibitor
Antibody
Investigational
Unknown
Unknown
Carcinoma, Hepatocellular; Neoplasms; Small Cell Lung Carcinoma; Hodgkin Disease; Lymphoma; Carcinoma, Non-Small-Cell Lung; Stomach Neoplasms
Programmed cell death 1 ligand 1 binding agent
Antibody
Investigational
Unknown
Unknown
Lipodystrophy, Congenital Generalized
Unknown
Antibody
Investigational
Unknown
Unknown
Arthritis, Rheumatoid; Diabetes Mellitus; Osteoarthritis
Interleukin-1 receptor antagonist
Antibody
Investigational
Unknown
Unknown
Lymphoma, Non-Hodgkin
Integrin beta-2 inhibitor
Antibody
Investigational
Unknown
Unknown
Arthritis, Rheumatoid; Psoriasis
T-cell surface antigen CD4 agonist
Antibody
Investigational
Unknown
Unknown
Asthma
Interleukin-9 inhibitor
Antibody
Investigational
Unknown
Unknown
Glioma
Epidermal growth factor receptor erbB1 inhibitor
Antibody
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung; Neoplasms; Breast Neoplasms; Fallopian Tube Neoplasms; Ovarian Neoplasms; Peritoneal Neoplasms
Receptor tyrosine-protein kinase erbB-3 antagonist
Antibody
Investigational
Unknown
Unknown
Glioblastoma
DNA-histone H1 complex binding agent
Antibody
Investigational
Unknown
Unknown
Neoplasms; Prostatic Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Squamous Cell; Severe Acute Respiratory Syndrome
Interleukin-8 inhibitor
Antibody
Investigational
Unknown
Unknown
Alzheimer Disease
Beta amyloid A4 protein binding agent
Antibody
Investigational
Unknown
Unknown
Melanoma; Atherosclerosis; Cardiovascular Diseases; Diabetic Nephropathies; Multiple Sclerosis
C-C chemokine receptor type 2 inhibitor
Antibody
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute
Interleukin-3 receptor subunit alpha binding agent
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
Antibody
Investigational
Unknown
Unknown
Unknown
Lymphocyte differentiation antigen CD38 inhibitor
Antibody
Investigational
Unknown
Unknown
Hemoglobinuria, Paroxysmal; Macular Degeneration; Uveitis, Intermediate; Wet Macular Degeneration
Complement C5 binding agent
Antibody
Investigational
Unknown
Unknown
Arthritis, Psoriatic
Tumor necrosis factor receptor superfamily member 5 inhibitor
Antibody
Investigational
Unknown
Unknown
Unknown
T-cell differentiation antigen CD6 binding agent
Antibody
Investigational
Unknown
Unknown
Unknown
Tumor necrosis factor receptor superfamily member 5 partial agonist
Antibody
Investigational
Unknown
Unknown
Pneumonia
Lipopolysaccharide (LPS) inhibitor
Antibody
Investigational
Unknown
Unknown
Unknown
Glutamate carboxypeptidase II binding agent
Antibody
Investigational
Unknown
Unknown
Arthritis, Rheumatoid; Celiac Disease; Psoriasis; Vitiligo
Interleukin-15 inhibitor
Antibody
Investigational
Unknown
Unknown
Melanoma
Ganglioside GD3 other
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown